Skip to content

Job Openings
Contact Us

Main Menu

Our Science
Clinical Expertise
- Our Studies
- Our Publications
Our Company
Newsroom
Careers
- Job Openings

Main Menu

Our Science
Clinical Expertise
- Clinical Expertise
- Our Publications
About Our Company
Newsroom
Careers
Job Openings
Contact Us
X
LinkedIn

Prevention of Colorectal Cancer Through Multiomics Blood Testing: The PREEMPT CRC Study

by Girish Putcha, Chuanbo Xu, Aasma Shaukat, and Theodore R. Levin

PrevOlderEnrollment Rate Of African Americans In A Colon Cancer Screening Trial at a Historically Black College and University is Similar to Other Patient Populations

NewerMulti-level factors reported in colorectal cancer screening adherence studies reflect evolving challenges and opportunities in different care settings: A systematic reviewNext

Categories

Presentations
Manuscripts

279 East Grand Avenue
5th Floor
South San Francisco, CA
94080

©2024 Freenome Holdings, Inc. The following are registered trademarks of Freenome Holdings, Inc.: FREENOME®, PREEMPT CRC® and AI-EMERGE®. All rights reserved.

Services
About
Reviews
Why Us
Contact
Home

Services
About
Reviews
Why Us
Contact
Home